Loading…
Operates in Pharma — Production. Per the activity note to the FY2024 annual report, the company produces pharmaceutical preparations.
Group parent — controls 1 company · ownership
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | CAGR |
|---|---|---|---|---|---|---|---|---|
| Net Cash from Operating Activities | 41 | 40 | 32 | 100 | 423 | 99 | 289 | nmf |
| Net Change in Cash (before FX) | 41 | 40 | 32 | 100 | 423 | 99 | 289 | nmf |
| Effect of FX on Cash | 0 | 1 | 2 | 1 | 79 | 1 | 4 | nmf |
| Net Change in Cash (incl. FX) | 41 | 38 | 34 | 98 | 344 | 100 | 293 | nmf |
| Cash at Beginning of Year | 299 | 340 | 378 | 412 | 314 | 658 | 557 | +10.9% |
| Cash at End of Year | 340 | 378 | 412 | 314 | 658 | 557 | 264 | -4.1% |
Shareholders, directors and group links from the companyinfo.ge public register — as filed, so stakes need not sum to 100% where a holding is undisclosed.
Ownership & directors from companyinfo.ge (public corporate registry).
Ranked by how close each latest revenue is to this one — not a curated comp set.